Nanobodies and their derivatives: pioneering the future of cancer immunotherapy

Nanobodies and their derivatives: pioneering the future of cancer immunotherapy

Abstract Cancer immunotherapy, which boosts the immune system to recognize and attack malignant cells, has revolutionized traditional cancer treatment paradigms. Approaches such as chimeric antigen receptor T cell (CAR-T) therapy and immune checkpoint inhibitors (ICIs) have demonstrated promising th...

Full description

Saved in:
Bibliographic Details
Main Authors: Haixia Li, Quan Zhou, Nan Cao, Chenghao Hu, Jincheng Wang, Yu He, Shan Jiang, Qi Li, Miao Chen, Li Gong, Ming Luo, Xinzhou Deng, Zhiguo Luo
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Cell Communication and Signaling
Subjects:
Nanobody
Cancer immunotherapy
CAR-T therapy
Immune checkpoint inhibitors
Immune cell engaging antibodies
Online Access:https://doi.org/10.1186/s12964-025-02270-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12964-025-02270-4

Similar Items